NCT04413929View on ClinicalTrials.gov

Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients.

CompletedOBSERVATIONAL
Enrollment

8,411

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

April 30, 2017

Study Completion Date

April 30, 2017

Conditions
Viral Respiratory Infection
Interventions
DRUG

Ergoferon

Oral administration

Sponsors
All Listed Sponsors
lead

Materia Medica Holding

INDUSTRY

NCT04413929 - Study on Safety and Effectiveness of Ergoferon in the Treatment of Flu / ARVI in Outpatients. | Biotech Hunter | Biotech Hunter